Neuberg Diagnostics to launch up to ₹4,000cr IPO in FY28
Neuberg Diagnostics, known for its work in genomics and health testing, plans to go public in fiscal 2028 with an IPO worth up to ₹4,000 crore.
Founder and chairman GSK Velu says the offering will include new shares and a chance for early investors to cash out.
The move is part of Neuberg's push to grow bigger and reach more people across India.
Neuberg raising ₹500cr for acquisitions
Before the IPO, Neuberg is raising ₹500 crore over the next few months to fund acquisitions and expand nationwide.
They're also investing up to ₹1,000 crore from various sources into new tech like genomics testing, and longevity programs, hoping these will make up one-quarter of their revenue soon.
With a new center opening in Mumbai and big growth targets in Delhi-NCR and Maharashtra, Neuberg aims to become India's second-largest diagnostics provider.
Velu sounds confident: "We believe we can be in a strong position to emerge as the number two player."